دورية أكاديمية
أعرض في EDS

Increase in treatment of retinopathy of prematurity in the Netherlands from 2010 to 2017.

التفاصيل البيبلوغرافية
العنوان: Increase in treatment of retinopathy of prematurity in the Netherlands from 2010 to 2017.
المؤلفون: Trzcionkowska K; Leiden University Medical Center, Leiden, Netherlands., Vehmeijer WBHJ; Leiden University Medical Center, Leiden, Netherlands., Kerkhoff FT; Maxima Medical Center, Veldhoven, Netherlands., Bauer NJC; Maastricht University Medical Centre, Maastricht, Netherlands., Bennebroek CAM; Amsterdam University Medical Center, Amsterdam, Netherlands., Dijk PH; University Medical Center Groningen, Groningen, Netherlands., Dijkman KP; Maxima Medical Center, Veldhoven, Netherlands., van den Dungen FAM; Amsterdam University Medical Center, Amsterdam, Netherlands., Eggink CA; Radboud University Medical Center - Amalia Children's Hospital, Nijmegen, Netherlands., Feenstra RPG; Isala Hospital, Zwolle, Netherlands., Groenendaal F; Wilhelmina Children's Hospital, Utrecht, Netherlands., van Heijst AF; Radboud University Medical Center - Amalia Children's Hospital, Nijmegen, Netherlands., van der Hoeven MAHBM; Maastricht University Medical Centre, Maastricht, Netherlands., Kornelisse RF; Erasmus University Medical Center, Rotterdam, Netherlands., Kraal-Biezen E; Amsterdam University Medical Center, Amsterdam, Netherlands., Lopriore E; Leiden University Medical Center, Leiden, Netherlands., Onland W; Amsterdam University Medical Center, Amsterdam, Netherlands., Renardel de Lavalette VW; University Medical Center Groningen, Groningen, Netherlands., van Rijn LJ; Amsterdam University Medical Center, Amsterdam, Netherlands., Schuerman FABA; Isala Hospital, Zwolle, Netherlands., Simonsz HJ; Erasmus University Medical Center, Rotterdam, Netherlands., Voskuil-Kerkhof ESM; Wilhelmina Children's Hospital, Utrecht, Netherlands., Witlox RSGM; Leiden University Medical Center, Leiden, Netherlands., Termote JUM; Wilhelmina Children's Hospital, Utrecht, Netherlands., Schalij-Delfos NE; Leiden University Medical Center, Leiden, Netherlands.
المصدر: Acta ophthalmologica [Acta Ophthalmol] 2021 Feb; Vol. 99 (1), pp. 97-103. Date of Electronic Publication: 2020 Jul 23.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101468102 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-3768 (Electronic) Linking ISSN: 1755375X NLM ISO Abbreviation: Acta Ophthalmol Subsets: MEDLINE
أسماء مطبوعة: Publication: Oxford, UK : Wiley-Blackwell
Original Publication: Oxford, UK ; Malden, MA : Blackwell Munksgaard
مواضيع طبية MeSH: Visual Acuity*, Bevacizumab/*administration & dosage , Laser Coagulation/*methods , Retinopathy of Prematurity/*therapy, Angiogenesis Inhibitors/administration & dosage ; Female ; Follow-Up Studies ; Gestational Age ; Humans ; Incidence ; Infant ; Infant, Newborn ; Intravitreal Injections ; Male ; Netherlands/epidemiology ; Retinopathy of Prematurity/diagnosis ; Retinopathy of Prematurity/epidemiology ; Retrospective Studies ; Vascular Endothelial Growth Factor A/antagonists & inhibitors
مستخلص: Purpose: Compare patients treated for Retinopathy of Prematurity (ROP) in two consecutive periods.
Methods: Retrospective inventory of anonymized neonatal and ophthalmological data of all patients treated for ROP from 2010 to 2017 in the Netherlands, subdivided in period (P)1: 1-1-2010 to 31-3-2013 and P2: 1-4-2013 to 31-12-2016. Treatment characteristics, adherence to early treatment for ROP (ETROP) criteria, outcome of treatment and changes in neonatal parameters and policy of care were compared.
Results: Overall 196 infants were included, 57 infants (113 eyes) in P1 and 139 (275 eyes) in P2, indicating a 2.1-fold increase in ROP treatment. No differences were found in mean gestational age (GA) (25.9 ± 1.7 versus 26.0 ± 1.7 weeks, p = 0.711), mean birth weight (791 ± 311 versus 764 ± 204 grams, p = 0.967) and other neonatal risk factors for ROP. In P2, the number of premature infants born <25 weeks increased by factor 1.23 and higher oxygen saturation levels were aimed at in most centres. At treatment decision, 59.6% (P1) versus 83.5% (P2) (p = 0.263) infants were classified as Type 1 ROP (ETROP classification). Infants were treated with laser photocoagulation (98 versus 96%) and intravitreal bevacizumab (2 versus 4%). Retreatment was necessary in 10 versus 21 (p = 0.160). Retinal detachment developed in 6 versus 13 infants (p = 0.791) of which 2 versus 6 bilateral (p = 0.599).
Conclusion: In period 2, the number of infants treated according to the ETROP criteria (Type 1) increased, the number of ROP treatments, retinal detachments and retreatments doubled and the absolute number of retinal detachments increased. Neonatal data did not provide a decisive explanation, although changes in neonatal policy were reported.
(© 2020 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.)
References: Br J Ophthalmol. 2015 Jun;99(6):807-11. (PMID: 25427778)
Behav Brain Res. 1992 Jul 31;49(1):1-6. (PMID: 1388792)
Pediatrics. 2004 Jun;113(6):1653-7. (PMID: 15173486)
N Engl J Med. 2011 Feb 17;364(7):603-15. (PMID: 21323540)
Br J Ophthalmol. 2016 Dec;100(12):1656-1661. (PMID: 26969711)
Acta Ophthalmol. 2016 Dec;94(8):e744-e752. (PMID: 27197876)
J Pediatr. 2000 Nov;137(5):608-16. (PMID: 11060524)
Acta Ophthalmol. 2018 Mar;96(2):142-148. (PMID: 29068172)
Pediatrics. 2015 Aug;136(2):343-50. (PMID: 26169424)
Arch Dis Child. 1982 Jun;57(6):410-7. (PMID: 7092304)
Neonatology. 2014;105(1):55-63. (PMID: 24247112)
Ned Tijdschr Geneeskd. 2017;161:D1168. (PMID: 28589868)
J AAPOS. 2013 Dec;17(6):650-2. (PMID: 24200805)
Arch Ophthalmol. 2005 Jul;123(7):991-9. (PMID: 16009843)
Pediatrics. 2013 Jul;132(1):62-71. (PMID: 23733804)
Br J Ophthalmol. 2013 Sep;97(9):1143-7. (PMID: 23823079)
Trans Am Ophthalmol Soc. 2004;102:233-48; discussion 248-50. (PMID: 15747762)
Cochrane Database Syst Rev. 2017 Apr 11;4:CD011190. (PMID: 28398697)
Lancet. 2013 Oct 26;382(9902):1445-57. (PMID: 23782686)
Arch Dis Child Fetal Neonatal Ed. 2007 Jul;92(4):F251-4. (PMID: 17251225)
Br J Ophthalmol. 2014 Aug;98(8):1056-60. (PMID: 24682181)
J Pediatr. 2014 Mar;164(3):494-498.e1. (PMID: 24360994)
Arch Dis Child Fetal Neonatal Ed. 2008 Nov;93(6):F403-6. (PMID: 18676408)
Eye Brain. 2016;8:67-79. (PMID: 27499653)
Dtsch Arztebl Int. 2015 Oct 23;112(43):730-5. (PMID: 26568177)
Pediatrics. 2008 Jan;121(1):97-105. (PMID: 18166562)
J Clin Invest. 2010 Sep;120(9):3022-32. (PMID: 20811158)
Ned Tijdschr Geneeskd. 2010;154:A2701. (PMID: 21429260)
Trans Am Ophthalmol Soc. 2010 Dec;108:96-119. (PMID: 21212851)
فهرسة مساهمة: Keywords: guideline; laser photocoagulation; retinopathy of prematurity; treatment
المشرفين على المادة: 0 (Angiogenesis Inhibitors)
0 (Vascular Endothelial Growth Factor A)
2S9ZZM9Q9V (Bevacizumab)
تواريخ الأحداث: Date Created: 20200724 Date Completed: 20210906 Latest Revision: 20210906
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC7891652
DOI: 10.1111/aos.14501
PMID: 32701185
قاعدة البيانات: MEDLINE
الوصف
تدمد:1755-3768
DOI:10.1111/aos.14501